Total Payments
$895.05
2020 Payments
$14.10
Companies
16
Transactions
70
Medicare Patients
10,741
Medicare Billing
$644,432
Payment Breakdown by Category
Food & Beverage$841.60 (94.0%)
Education$53.45 (6.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $841.60 | 69 | 94.0% |
| Education | $53.45 | 1 | 6.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $405.16 | 36 | $0 (2020) |
| Novo Nordisk Inc | $107.32 | 6 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $80.75 | 6 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $62.51 | 3 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $53.45 | 1 | $0 (2017) |
| Gilead Sciences, Inc. | $32.07 | 2 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $28.36 | 6 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $21.59 | 2 | $0 (2017) |
| Abbott Laboratories | $16.80 | 1 | $0 (2018) |
| Resmed Corp | $13.75 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $14.10 | 1 | GlaxoSmithKline, LLC. ($14.10) |
| 2019 | $292.31 | 24 | GlaxoSmithKline, LLC. ($125.77) |
| 2018 | $273.23 | 20 | GlaxoSmithKline, LLC. ($146.14) |
| 2017 | $315.41 | 25 | GlaxoSmithKline, LLC. ($119.15) |
All Payment Transactions
70 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/12/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: RESPIRATORY | ||||||
| 12/13/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: RESPIRATORY | ||||||
| 11/22/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $0.28 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: Diabetes | ||||||
| 11/05/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Respiratory | ||||||
| 10/24/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Diabetes | ||||||
| 10/16/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $5.22 | General |
| Category: RESPIRATORY | ||||||
| 10/11/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: RESPIRATORY | ||||||
| 10/10/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $0.24 | General |
| Category: RESPIRATORY | ||||||
| 09/24/2019 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: Pulmonology | ||||||
| 09/05/2019 | Sunovion Pharmaceuticals Inc. | BROVANA (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Respiratory | ||||||
| 08/27/2019 | Tactile Systems Technology Inc | FLEXITOUCH (Device), ACTITOUCH, ENTRE | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 08/08/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), ANORO | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: RESPIRATORY | ||||||
| 07/25/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Respiratory | ||||||
| 06/04/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: RESPIRATORY | ||||||
| 06/04/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $0.43 | General |
| Category: RESPIRATORY | ||||||
| 05/07/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: RESPIRATORY | ||||||
| 05/02/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Diabetes | ||||||
| 04/16/2019 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: DIABETES | ||||||
| 04/01/2019 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: RESPIRATORY | ||||||
| 02/05/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: RESPIRATORY | ||||||
| 01/23/2019 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Respiratory and Allergy | ||||||
| 01/22/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: Respiratory | ||||||
| 01/10/2019 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,109 | 1,230 | $230,105 | $48,441 |
| 2022 | 23 | 1,971 | 2,793 | $512,025 | $172,888 |
| 2021 | 34 | 3,506 | 4,754 | $532,752 | $211,256 |
| 2020 | 37 | 4,155 | 5,780 | $609,541 | $211,847 |
Total Patients
10,741
Total Services
14,557
Medicare Billing
$644,432
Procedure Codes
115
All Medicare Procedures & Services
115 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 274 | 342 | $120,384 | $22,685 | 18.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 271 | 309 | $77,250 | $16,994 | 22.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $9,200 | $1,585 | 17.2% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 29 | 30 | $4,890 | $1,209 | 24.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 94 | 96 | $2,880 | $993.60 | 34.5% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 27 | 28 | $4,228 | $950.35 | 22.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 127 | 134 | $804.00 | $787.92 | 98.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 57 | 58 | $2,204 | $760.96 | 34.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 30 | 31 | $3,348 | $737.49 | 22.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 86 | 86 | $1,892 | $654.46 | 34.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 39 | 41 | $1,107 | $390.32 | 35.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 18 | 18 | $846.00 | $296.28 | 35.0% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 13 | 13 | $676.00 | $245.96 | 36.4% |
| 83721 | Ldl cholesterol level | Office | 2023 | 12 | 12 | $324.00 | $123.48 | 38.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 12 | 12 | $72.00 | $26.40 | 36.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 600 | 1,326 | $343,070 | $114,253 | 33.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 188 | 215 | $39,509 | $12,677 | 32.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 91 | 91 | $33,540 | $11,777 | 35.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 42 | 43 | $14,435 | $5,690 | 39.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 104 | 108 | $14,484 | $4,886 | 33.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 28 | 28 | $13,357 | $4,642 | 34.8% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 97 | 100 | $12,796 | $4,056 | 31.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 103 | 107 | $12,960 | $3,189 | 24.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 80 | 82 | $4,264 | $2,409 | 56.5% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 14 | 14 | $5,096 | $2,334 | 45.8% |
About Dr. Gordon Wolfe, MD
Dr. Gordon Wolfe, MD is a Pulmonary Disease healthcare provider based in Winchester, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1649238437.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gordon Wolfe, MD has received a total of $895.05 in payments from pharmaceutical and medical device companies, with $14.10 received in 2020. These payments were reported across 70 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($841.60).
As a Medicare-enrolled provider, Wolfe has provided services to 10,741 Medicare beneficiaries, totaling 14,557 services with total Medicare billing of $644,432. Data is available for 4 years (2020–2023), covering 115 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Winchester, VA
- Active Since 05/02/2006
- Last Updated 05/28/2021
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1649238437
Products in Payments
- TRELEGY ELLIPTA (Drug) $155.12
- ANORO (Drug) $141.20
- BREO (Drug) $108.84
- SYMBICORT (Drug) $67.39
- ELIQUIS (Drug) $62.51
- Ozempic (Drug) $54.86
- Tresiba (Drug) $42.00
- BROVANA (Drug) $17.43
- Letairis (Drug) $17.04
- Proclaim Family of SCS IPGs (Device) $16.80
- Astral (Device) $13.75
- Yupelri (Drug) $13.61
- FLEXITOUCH (Device) $13.18
- Prolastin-C Liquid (Biological) $12.97
- TOUJEO (Drug) $12.17
- NAMZARIC (Drug) $10.96
- UTIBRON (Drug) $10.93
- ZOSTAVAX (Biological) $10.86
- JANUVIA (Drug) $10.73
- Victoza (Drug) $10.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Winchester
T. Bouder, Md, MD
Pulmonary Disease — Payments: $143,021
Pulmonary Disease $143,021
Santa Dalessio, Md, MD
Pulmonary Disease — Payments: $51,548
Pulmonary Disease $51,548
Dr. Christian Lafalce, M.d, M.D
Pulmonary Disease — Payments: $19,760
Pulmonary Disease $19,760
Dr. Oscar Hernandez-Cano, M.d, M.D
Pulmonary Disease — Payments: $4,815
Pulmonary Disease $4,815
Thomas Murphy, Md, MD
Pulmonary Disease — Payments: $2,789
Pulmonary Disease $2,789
Dr. David Lecronier, D.o, D.O
Pulmonary Disease — Payments: $540.82
Pulmonary Disease $540.82